Treatment with the Catalytic Metalloporphyrin AEOL 10150 Reduces Inflammation and Oxidative Stress Due to Inhalation of the Sulfur Mustard Analog 2-chloroethyl Ethyl Sulfide
Overview
Biology
General Medicine
Authors
Affiliations
Sulfur mustard (bis-2-(chloroethyl) sulfide; SM) is a highly reactive vesicating and alkylating chemical warfare agent. A SM analog, 2-chloroethyl ethyl sulfide (CEES), has been utilized to elucidate mechanisms of toxicity and as a screen for therapeutics. Previous studies with SM and CEES have demonstrated a role for oxidative stress as well as decreased injury with antioxidant treatment. We tested whether posttreatment with the metalloporphyrin catalytic antioxidant AEOL 10150 would improve outcome in CEES-induced lung injury. Anesthetized rats inhaled 5% CEES for 15 min via a nose-only inhalation system. At 1 and 9 h after CEES exposure, rats were given AEOL 10150 (5 mg/kg, sc). At 18 h post-CEES exposure BALF lactate dehydrogenase activity, protein, IgM, red blood cells, and neutrophils were elevated but were decreased by AEOL 10150 treatment. Lung myeloperoxidase activity was increased after CEES inhalation and was ameliorated by AEOL 10150. The lung oxidative stress markers 8-OHdG and 4-HNE were elevated after CEES exposure and significantly decreased by AEOL 10150 treatment. These findings demonstrate that CEES inhalation increased lung injury, inflammation, and oxidative stress, and AEOL 10150 was an effective rescue agent. Further investigation utilizing catalytic antioxidants as treatment for SM inhalation injury is warranted.
Epigenetic mechanisms of alveolar macrophage activation in chemical-induced acute lung injury.
Ahmad S, Nasser W, Ahmad A Front Immunol. 2024; 15:1488913.
PMID: 39582870 PMC: 11581858. DOI: 10.3389/fimmu.2024.1488913.
Oxidative Stress: An Intersection Between Radiation and Sulfur Mustard Lung Injury.
Day B Disaster Med Public Health Prep. 2024; 18:e86.
PMID: 38706344 PMC: 11218645. DOI: 10.1017/dmp.2023.238.
Satyamitra M, Andres D, Bergmann J, Hoffman C, Hogdahl T, Homer M Disaster Med Public Health Prep. 2023; 17:e552.
PMID: 37852927 PMC: 10843005. DOI: 10.1017/dmp.2023.176.
Liang L, Pearson-Smith J, Day B, Patel M J Pharmacol Exp Ther. 2023; 388(2):358-366.
PMID: 37652711 PMC: 10801718. DOI: 10.1124/jpet.123.001708.
Cruz-Hernandez A, Roney A, Goswami D, Tewari-Singh N, Brown J Inhal Toxicol. 2022; 34(13-14):412-432.
PMID: 36394251 PMC: 9832991. DOI: 10.1080/08958378.2022.2147257.